DR MIRIAM & SHELDON G ADELSON CLINIC FOR DRUG ABUSE TREATMENT & RESEARCH INC (EIN 880401489) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1998

Legal Domicile

Principal Officer

DR MIRIAM ADELSON

Phone

7027357900

Tax Period

2023-01-01 to 2023-12-31

DR MIRIAM & SHELDON G ADELSON CLINIC FOR DRUG ABUSE TREATMENT & RESEARCH INC, founded in 1998, is a community nonprofit in the Health Care sector that reported $2.0M in total revenue in fiscal year 2023. Expenses of $1.9M left a modest 5% surplus.

Mission

THE CLINIC OPERATES A DRUG TREATMENT AND REHABILITATION CLINIC PROVIDING MEDICAL CARE TO AND REHAB PROGRAMS FOR OPIATE DEPENDENT PATIENTS, AND CONDUCTS RESEARCH ON THE EFFECTIVENESS OF DRUG TREATMENT PROGRAMS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $966,237

Program Service Revenue $1,003,436

Investment Income $8,072

Other Revenue $19,281

TOTAL REVENUE $1,997,026

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,229,531

Fundraising Expenses $11,597

Program Expenses $1,740,421

Other Expenses $667,056

TOTAL EXPENSES $1,896,587

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,997,026	$2,062,200	0.0%
Expenses	$1,896,587	$1,994,702	0.0%
Net Income	$100,439	$67,498	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR MIRIAM ADELSON	CHAIRPERSON	20.00	Director	$0	$0	$0
NEVILLE POKROY	DIRECTOR	1.00	Director	$0	$0	$0
ROBERT GOLDSTEIN	DIRECTOR	1.00	Director	$0	$0	$0
PAUL SCHIFFMAN	DIRECTOR	1.00	Director	$0	$0	$0
DEANNA FORBUSH	DIRECTOR	1.00	Director	$0	$0	$0
JUSTICE MICHAEL A CHERRY	DIRECTOR	1.00	Director	$0	$0	$0
DINITA SMITH	CLINIC DIRECTOR	40.00	Highest	$141,820	$20,157	$161,977

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,997,026	$1,896,587	$5,541,977	$100,439
2022	$2,062,200	$1,994,702	$5,394,990	$67,498
2021	$1,850,799	$1,800,997	$5,387,759	$49,802
2020	$1,965,086	$1,991,424	$5,326,983	$-26,338
2019	$1,898,793	$1,767,811	$5,305,460	$130,982
2018	$1,463,575	$1,527,980	$5,222,508	$-64,405

DR MIRIAM & SHELDON G ADELSON CLINIC FOR DRUG ABUSE TREATMENT & RESEARCH INC